ARTICLE | Clinical News
Marqibo vincristine regulatory update
October 4, 2004 7:00 AM UTC
The partners said FDA's Oncologic Drugs Advisory Committee will review an NDA for Marqibo to treat relapsed, aggressive non-Hodgkin's lymphoma (NHL) previously treated with at least two combination ch...